1. 528 Intratumoural treatment with LTX-, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces CD8 effector cells and regression in some injected tumours. (September 2015) Authors: Spicer, J.; Awada, A.; Brunsvig, P.; Saunders, A.; Olsen, W.M.; Nicolaisen, B.; Rekdal, O.; Laruelle, M.; Marjuadi, F.; Vakili, J.; Aftimos, P.; Barthelemy, P.; Deva, S.; Baurain, J.F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 92OThe Breast International Group (BIG) AURORA pilot study for molecular screening in metastatic breast cancer (MBC) patients. (7th May 2015) Authors: Maetens, M.; Irrthum, A.; Loibl, S.; Laes, J.F.; Campbell, P.; Aftimos, P.; Thompson, A.; Cortes Castan, J.; Loi, S.; Sotiriou, C. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 3 Page Start: iii31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1185 Targeting therapy-resistant metastatic clones with SBRT in oligoprogressive breast cancer. (May 2022) Authors: Van den Begin, R.; Bellal, S.; De Caluwé, A.; Aftimos, P.; Paquier, Z.; Gebhart, G.; Buisseret, L.; Martinive, P.; Lefranc, F.; Van Gestel, D. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗